Medican appoints Morten Snede as new CEO

Morten Snede takes over the role of CEO of the Danish-owned cannabis company Medican A/S.

 On 24th October 2022, Morten Snede took his seat in the director’s chair of the pharmaceutical and cannabis company Medican A/S that produces cannabis for medical use.

The board has chosen Morten Snede due to his many years of experience with the management role coupled with his work in the cannabis industry as CEO of the Danish subsidiary of Canopy Growth Corp., which was taken over by Australian Little Green Pharma Ltd. in 2021. He also has a reputation for being a skilled and empathetic leader, thus gifting Medican with a pedigreed strategist and visionary.

»Medican is a significant Danish player on the European market for medical cannabis. I’m very much looking forward to using my experience to help ensure an even stronger and brighter future for Medican, patients, employees, business partners, and shareholders, « says Morten Snede.

Morten Snede’s industry-specific experience as CEO of first Canopy Growth Denmark and subsequently Little Green Pharma has been a determining factor in the selection of the new Chief Executive Officer.

»Morten brings a versatile financial, legal, and commercial experience, as well as a comprehensive knowledge of the cultivation and distribution of medical cannabis in Europe, to the table. Also, he’s an experienced and very passionate leader with the right qualifications to bring Medican into a new era as a leader in the proliferation of cannabis for medical use in Europe, « says Brian Palm Svaneeng Mertz, Medican’s Chairman of the Board.

Morten Snede replaces the Company’s current CEO, Dennis Jørgensen, who remains on the Medican Management team

Please direct any and all questions and/or comments to Medican A/S in an email to